Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
High Purity NK Cell Therapy
- Development stage
- Preclinical
- Lead developer
- Vectorite Biomedical
- Modality
- CAR-NK Cells → Other Engineered Cells → Adoptive Cell Transfer → Cell Therapies, Lymphokine-Activated Killer Cells → Native Immune Cells → Adoptive Cell Transfer → Cell Therapies
- Administration
- Intravenous
01
Overview
High Purity NK Cell Therapy is an adoptive immunotherapy developed by Vectorite Biomedica (鑫品生醫). The therapy utilizes a proprietary expansion and purification technology, licensed from Japan, to produce medical-grade natural killer (NK) cells derived from lymphoid progenitor cells. These high-purity NK cells are designed to perform non-specific attacks on cancer cells through direct cytotoxicity and the secretion of cytokines that modulate the patient's immune response. The treatment is intended for personalized cancer immunotherapy and has received regulatory approval for clinical application in Taiwan under specific cell therapy regulations.
- Other names
- 高純度NK細胞技術High Purity Natural Killer Cell Technology
Beyond the preview
Go deeper on High Purity NK Cell Therapy.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on High Purity NK Cell Therapy.